Active RAS/MAPK signaling in cancer cells induces the expression of negative regulators of the RAS/MAPK pathway, such as MAPK phosphatases (e.g., DUSP4) and Sprouty (Spry) proteins (Lake et al., 2016). The gene discussed is DUSP4; the disease is cancer.